WBMT 2025 - Symposium Faculty
- Home
- »
- Symposium Faculty
WBMT Faculty

Damiano Rondelli, MD
Michael Reese Professor of Hematology
Chief, Division of Hematology/Oncology
Director, Blood & Marrow Transplant and Cell Therapy, Dept of Medicine
Director for Global Partnerships, Center for Global Health
College of Medicine
Damiano Rondelli, MD
Chicago, USA

Dietger W Niederwieser, MD
Professor of Medicine
Conc. Professor mult; Drs. h. c.
Leipzig, Germany
Adjunct Professor
Center for Cellular Immunotheraphies
University of Pennsylvania & Penn Medicine
Philadelphia, USA
Dietger W Niederwieser, MD
Leipzig, Germany

Mahmoud Deeb Saeed M Aljurf
Professor of Medicine at Alfaisal University
Director of the Adult Stem Cell Transplantation and Cell Therapy Program and Deputy Director of the Oncology Centre
King Faisal Specialist Hospital & Research Centre
Riyadh, Saudi Arabia
Mahmoud Deeb Saeed M Aljurf
Riyadh, Saudi Arabia

Mickey B. C. Koh
Professor Mickey Koh received his medical degree at the National University of Singapore followed by all of his subsequent specialist Haematology training (FRCPath, MRCP and PhD) in London.
He holds several joint positions. Prof Koh is the Clinical Director of the Haematology, Renal and Oncology Departments at St George’s University Hospital, London, UK and part of Infection and Immunity Academic Group at St George’s Medical School.
He is also Professor and Honorary Consultant of the Advanced Cell Therapy and Research Institute (ACTRIS) in Singapore involved in cell and gene therapy trials across haemato-oncology and regenerative medicine.
Professor Mickey Koh has been appointed as part of the Expert Advisory Panel at the World Health Organisation and sits on the Expert Committee on Biological Standardisation.
He is the current Vice-President of the Worldwide Network for Blood and Marrow Transplantation (WBMT) and a past Board member of the International Society of Cellular Therapy (ISCT). He is also on the Board of Directors for ISBT and ICCBBA, an international organisation overseeing the standard for terminology, coding and labelling of medical products of human origin.
Mickey Koh
London, UK; Singapore

Santhosh Devadas
HOD & Consultant – Department of Medical Oncology; Chief – Bone Marrow Transplant; Professor / HOD
Ramaiah Institute of Oncosciences, Ramaiah Memorial Hospital; M.S. Ramaiah Medical College & Hospital
Bengaluru (Bangalore), India
Santhosh Devadas
Bengaluru (Bangalore), India

Helen Baldomero
Contributor to Hematopoietic Stem Cell Transplantation and cellular therapy activity surveys.
WBMT Transplant Activity Survey Office – Division of Hematology, University Hospital Basel
Basel, Switzerland
Coordinater of international data collection and performance of in-depth analyses on hematopoietic stem cell transplantation and cellular therapy through the WBMT Transplant and Cellular Therapy Activity Surveys. My work focuses on ensuring analytical accuracy and transforming global data into insights that support evidence-based clinical practice, inform policy, and strengthen international research collaborations to advance transplantation and cellular therapy worldwide
Helen Baldomero
Basel, Switzerland

Laurent Garderet
Hematologist; Principal Investigator in clinical studies
Pitié-Salpêtrière University Hospital – AP-HP, Sorbonne University
Paris, France
Dr laurent Garderet is a French hematologist working in the hematology department at Pitié Salpêtrière Hospital in Paris, France. He did his medical studies as well as his training in Paris. He also did a post-doctoral internship in the transplant department of the M.D Anderson Cancer Center in Houston under the supervision of Dr Richard Champlin. His main interests focus on myeloma treatment and biology. He is a board member of the Intergroupe Francophone du Myélome and the past chairman of the Plasma Cell Disorder subcommittee of the EBMT Chronic Malignancies Working Party. He is also a member of the International Myeloma Society (IMS) as well as the International Kidney Monoclonal Gammopathy (IKMG) research group.
Laurent Garderet
Paris, France

Nina Worel
Deputy chair of the department
Specialist for Transfusion Medicine, general practitioner and emergency physician
Division management therapeutic and preparative apheresis
Head of ATMPs manufacturing
Head of tissue establishment
Responsible person tissue & cell directive
Vienna, Austria
Nina Worel
Vienna, Austria

Hildegard T. Greinix
Professor of Hematology and Oncology at the Medical University Vienna, Department of Internal Medicine I/BMT
Vienna, Austria
Hildegard T. Greinix
Vienna, Austria

Fabian Müller
Professor for CAR T cell Therapy, head of the cell therapy unit
Department of Internal Medicine 5 – Hematology and Oncology
University Hospital of Erlangen, Friedrich-Alexander-University of Erlangen Nürnberg
Prof. Müller obtained his MD in Freiburg, Germany and started his clinical education in Hamburg. Initially with a focus on targeting malignant B cells through BCR recognition, he then did his postdoc with Dr. Ira Pastan, NCI, NIH, on resistance to CD22-targeted therapy in ALL and aggressive lymphoma. After his post-doc he continued the work on B cell targeting in Erlangen, Germany using antibody directed therapies at first and then CAR T cells with a focus on translational concepts including tumor microenvironment and functional aspects of a patient’s immune system. As head of the CAR T cell unit, he pioneers CAR T cell therapies in novel indications including solid tumors and autoimmune diseases.
Fabian Müller
Saarbrücken, Germany

Anant Gokarn
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre.
Mumbai, India
Anant Gokarn
Mumbai, India

Rizwan Javed
M.B.B.S, M.D (Path),
Fellowship (Transfusion Medicine)
MSc (Transfusion & Transplantation Sciences)
Consultant in Apheresis & Cellular therapy (manufacturing) with the Bone marrow transplant team at TATA Medical Center, Kolkata,India
Commonwealth Scholar 2017/18, trained at NHS Blood & Transplant (IBGRL), in Bristol
FACT Inspector
Kolkata, India
Rizwan Javed
Kolkata, India

Reetu Jain
Medical oncologist and BMT Physician
Director BMT and Academics
Jaslok Hospital and Research centre
Mumbai, India
Reetu Jain
Mumbai, India

Rahul Purwar
Indian Institute of Technology of Bombay
Department of Biosciences and Bioengineering
Mumbai, India
Rahul Purwar
Mumbai, India

Madhav Danthala MD, DM (Medical Oncology)
Fellowship in leukemia/BMT (UBC, Canada)
Sr. Consultant Medical Oncologist, Hemato Oncologist, & Bone Marrow Transplant Physician
Omega Hospitals, Gachibowli, Hyderabad, India
Madhav Danthala MD, DM (Medical Oncology)
Hyderabad, India

Uday Prakash Kulkarni
Christian Medical College Vellore
Vellore, Tamil Nadu, India
Uday Prakash Kulkarni
Vellore, Tamil Nadu, India

Franco Locatelli
Professor of Pediatrics at the Università Cattolica del Sacro Cuore and Head of the Department of Paediatric Haematology and Oncology and Cell and Gene Therapy at the Bambino Gesù Children’s Hospital in Rome, Italy
Franco Locatelli
Rome, Italy

Adriana Seber
Brazil
Adriana Seber
Brazil

Marco Ruella, MD
University of Pennsylvania
Philadelphia, Pennsylvania, USA
Marco Ruella, MD
Pennsylvania, USA

Prashant Mehta, MD, DM
Senior Consultant and Program Head – Lymphoid Neoplasms and Cellular Therapy
Editor-in-Chief, International Journal of Molecular and Immuno-Oncology
Hematology / Medical Oncology and Bone Marrow Transplant
Amrita Institute of Medical Sciences
Faridabad, India
Prashant Mehta, MD, DM
Faridabad, India

Sebastian Galeano
Hospital Británico
Montevideo-Uruguay
Sebastian Galeano is a member of the Hospital Británico Hematology Department-Hematopoietic Cell Transplant Program and Associate Professor of Hematology at the CLAEH University in Montevideo, Uruguay. He obtained his medical degree in 1996 and has postgraduate degrees in Internal Medicine and Hematology as well as certification in Bone Marrow Transplant from the Universidad de la República (UDELAR), Montevideo, Uruguay. He is President of the Sociedad de Hematología del Uruguay (SHU), Secretary of the Worldwide Network for Blood and Marrow Transplantation (WBMT) and Past-President of the Latin American Bone Marrow Transplantation Group (LABMT).
Sebastian Galeano
Montevideo, Uruguay

Shalini Chandrashekar Nooyi
Principal and Dean
Ramaiah Medical College
Bengaluru, India
Dr. Shalini Chandrashekar Nooyi is the Principal and Dean of MS Ramaiah Medical College, Bengaluru, India. She holds dual MD degrees in Pediatrics and Community Medicine and brings over 30 years of distinguished experience in teaching, research, and medical administration.
She began her career in Community Medicine at Manipal, focusing on Social Pediatrics in urban and rural settings, gaining valuable grassroots healthcare experience. Dr. Nooyi also contributed to non-communicable disease initiatives during her tenure with the Ministry of Health in Oman. Since joining Ramaiah Medical College in 2009, she has served in various academic roles, assuming her current leadership position since August 2022. Under her guidance, the college emphasizes nurturing well-rounded, empathetic physicians who become innovators and leaders in healthcare.
Shalini Chandrashekar Nooyi
Bengaluru, India

Sharat Damodar MD,DNB,DM
Clinical Director, MSMC
Chairman Oncology Collegium
Senior Consultant Haematologist and Head of Adult BMT
Mazumdar Shaw Medical Center
Bengaluru, India
Sharat Damodar MD,DNB,DM
Bengaluru, India

Christian Chabannon
Marseille, France
Prof. Christian Chabannon is a French physician, board certified in Hematology and Medical Oncology. He is a Professor of Medicine in Cell Biology at Aix-Marseille Université School of Medicine and a full member at Institut Paoli-Calmettes Comprehensive Cancer Center where he has been leading the Cell Collection and Cell Processing facilities for more than 20 years. He was a founder and head of the CBT-1409 Inserm – AMU – AP-HM – IPC, a multidisciplinary research initiative aiming at fostering development and evaluation of innovative cell and tissue -based advanced therapies in the Marseille metropolitan area. Prof. Chabannon is active in several EU professional associations, including EBMT where he served in various positions. He is a member of several national and international advisory boards. Pr Chabannon authored or co-authored more than 400 peer-reviewed publications”
Christian Chabannon
Marseille, France

Daniel Neumann
Leipzig, Germany
Daniel Neumann is from University Leipzig Institute of Medical Informatics, Statistics and Epidemiology, Leipzig (Germany).
He is the data scientist by hear. He co-founded the WBMTs eGTR and developed it to strengthen international collaboration on improving therapy using an open and scalable registry platform. He is the scientific program lead on emulated target trails using real world data on drug therapy research and multi-domain therapy quality. This includes the oversight on developing a drug therapy safety research platform that enrich real world data with clinical trails documentation. He is also a researcher on complex data fusion to build up longitudinal digital twins and causal inference towards individualized targeted therapies using AI.
Daniel Neumann
Leipzig, Germany

Joseph (Yossi) Schwartz
Omaha, Nebraska, USA
Dr. Schwartz received his MD from the Technion – Israel Institute of Technology and his MPH from Columbia University Mailman School of Public Health. Upon completion of his training, he pursued a decades-long career in promoting excellence in the field of Transfusion Medicine, Apheresis & Cellular Therapy across a multitude of facilities including Columbia University Irving Medical Center, Moffitt Cancer Center and recently joined FACT as their Senior Medical Officer. In these capacities, He amounted many years of experience directing Transfusion Medicine, Apheresis & Cellular Therapy Services.
Throughout his tenure in the field, Dr. Schwartz became an active member of the professional and academic community. He had been involved in many professional organizations including AABB, CAP, ISCT, and ASCP to name few. He served as the president of ASFA in 2018-2019 and is currently the President of the World Apheresis Association. He served on the writing committee of ASFA’s Therapeutic Apheresis guidelines for five editions. Furthermore, he promoted quality and standardization through dissemination of the FACT-JACIE international standards for cellular therapy. For these efforts and many more, he Have had earned many honors including the AABB Hemphill Jordan Leadership Award (2019), ASFA’s Presidential Award (2021), Francis Morrison lectureship Award (2023), and Lecturer award (2024).
Joseph (Yossi) Schwartz
Omaha, Nebraska, USA

Koji Kato, MD, PhD
Fukuoka, Japan
Department of Medicine and Biosystemic Science
Kyushu University Graduate School of Medical Sciences
Fukuoka, Japan
Koji Kato, MD, PhD
Fukuoka, Japan

Vinayak V Maka
Bengaluru (Bangalore), India
Dr. Vinayak V Maka is a senior Oncologist who teaches and practices at the Ramaiah Medical College. He is familiar with diagnosing and treating all types of malignancies and carrying out autologous and allogeneic stem cell transplantations. Dr. Maka currently specializes in providing personalized cancer care in Gastrointestinal cancers, Urological cancers, Head and Neck cancers, Lung cancers, sarcoma, brain tumors and skin cancers. As Professor and Head Of Department for Medical Oncology, Dr. Maka and his team were instrumental in starting and securing approval for a sub specialty degree (DM) in medical oncology for students per year from 2016 and in starting the stem cell transplantation program in 2015. He has also been involved in various investigator instigated and industry driven clinical research and also has multiple research grants for translational oncology including rectal cancer stem cells in collaboration with Indian Institute of Science, Bangalore under RGUHS research Grant.
Vinayak V Maka
Bengaluru (Bangalore), India

Abhijit Baheti
Pune, India
Abhijit Baheti
Pune, India

Ana Sureda
Barcelona, Spain
Anna Sureda is a clinical hematologist internationally recognized for her expertise in hematopoietic stem cell transplantation and cellular therapies. She currently serves as Head of the Hematology Department at the Institut Català d’Oncologia (ICO) in L’Hospitalet, Barcelona, Spain, and holds an academic appointment as Associate Professor of Hematology at the University of Barcelona.
Her clinical and research interests focus on the treatment of lymphoid malignancies—particularly Hodgkin and non-Hodgkin lymphomas—through innovative transplant strategies and immunotherapeutic approaches, including CAR-T cell therapy. She has played a pivotal role in advancing supportive care and the management of transplant-related complications.
Anna Sureda has held several prominent leadership positions at both the national and international levels. Most notably, she serves as President of the European Society for Blood and Marrow Transplantation (EBMT) until 2026, after being the secretary of the society from 2010 to 2016 and chairing the society’s Lymphoma Working Party between 2004 to 2010.
Ana Sureda
Barcelona, Spain

Atharva Karulkar
Mumbai, India
Co-founder and Head-Scientific Affairs, ImmunoACT, Mumbai, India
Dr. Atharva Karulkar completed his Ph.D. in Immunology from IIT Bombay, where he focused on the mechanisms of immune response and the development of innovative therapies for cancer treatment. His academic background laid the foundation for his passion for biomedical research.
He co-founded Immuno ACT with his PhD Supervisor Dr.Rahul Purwar with the mission of advancing immunotherapeutic approaches to combat various diseases, particularly cancer. Under their leadership, the company has pioneered several groundbreaking treatments that harness the body’s immune system to fight malignancies. His work emphasizes the integration of cutting-edge technology with clinical applications, bridging the gap between research and real-world patient care.
Dr. Karulkar’s research interests include:
- Cancer immunotherapy
- Cell and gene therapy
- Personalized medicine
- Mechanisms of immune evasion by tumors
Dr. Karulkar has authored numerous peer-reviewed publications and has presented his research at international conferences. He is actively involved in collaborative projects with leading research institutions.
With a commitment to innovation and patient-centered care, Dr. Karulkar aims to transform the landscape of cancer treatment through the development of safe, effective, and accessible immunotherapies.
Atharva Karulkar
Mumbai, India

BG Dharmanand
Bengaluru, India
Consultant, RheumaCare, Bengaluru
Chronic pain – Reproductive Immunology – Autoimmunity – Bedside teaching
BG Dharmanand
Bengaluru, India

Mobin Paul
Kochi, India
Aster Medcity, Kochi (Kerala), India
Mobin Paul
Kochi, India

Nishil Gowda
Bengaluru, India
Ramaiah Medical College, Bengaluru, India
Nishil Gowda
Bengaluru, India

Rasmi Palassery
Bengaluru, India
Ramaiah Medical College, Bengaluru, India
Rasmi Palassery
Bengaluru, India

Sanish Davis
Mumbai, India
Director, R&D, GCO J&J Innovative Medicines, India and Executive committee member, Indian Society for Clinical Research (ISCR)
Mumbai, India
Sanish Davis
Mumbai, India

Satyendra Katewa
Delhi, India
Satyendra Katewa
Delhi, India